6533b82ffe1ef96bd12948f1
RESEARCH PRODUCT
Apolipoprotein E Regulates Amyloid Formation within Endosomes of Pigment Cells.
Alessandra Lo CiceroAlessandra Lo CiceroGuillaume Van NielGuillaume Van NielGuillaume Van NielFlorent DingliIlse HurbainIlse HurbainIlse HurbainMarie-claude PotierGraça RaposoGraça RaposoGraça RaposoAurélie Di CiccoAurélie Di CiccoAurélie Di CiccoPtissam BergamPtissam BergamPtissam BergamLeon J. SchurgersDamarys LoewCecile FortCecile FortDaniel LévyDaniel LévyDaniel LévyRoberta PalmulliRoberta Palmullisubject
Apolipoprotein EAmyloidAmyloidEndosome[SDV.BC]Life Sciences [q-bio]/Cellular BiologyEndosomesBiologyExosomesGeneral Biochemistry Genetics and Molecular BiologyMiceApolipoproteins Emental disordersAnimalsHumansamyloid-related diseaseslcsh:QH301-705.5[SDV.BC] Life Sciences [q-bio]/Cellular BiologyMelanosomeMice KnockoutMelanosomesEndosomal Sorting Complexes Required for TransportVesicleMicrovesiclesPMELCell biologyMice Inbred C57BLlcsh:Biology (General)BiochemistryGene Expression RegulationMelanocytesSignal transductionHeLa CellsSignal Transductiondescription
International audience; Accumulation of toxic amyloid oligomers is a key feature in the pathogenesis of amyloid-related diseases. Formation of mature amyloid fibrils is one defense mechanism to neutralize toxic prefibrillar oligomers. This mechanism is notably influenced by apolipoprotein E variants. Cells that produce mature amyloid fibrils to serve physiological functions must exploit specific mechanisms to avoid potential accumulation of toxic species. Pigment cells have tuned their endosomes to maximize the formation of functional amyloid from the protein PMEL. Here, we show that ApoE is associated with intraluminal vesicles (ILV) within endosomes and remain associated with ILVs when they are secreted as exosomes. ApoE functions in the ESCRT-independent sorting mechanism of PMEL onto ILVs and regulates the endosomal formation of PMEL amyloid fibrils in vitro and in vivo. This process secures the physiological formation of amyloid fibrils by exploiting ILVs as amyloid nucleating platforms.
year | journal | country | edition | language |
---|---|---|---|---|
2015-10-06 | Cell reports |